ArticleBMC cancer2011

Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer.

Renquan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.